CDTX
Price
$63.17
Change
-$1.76 (-2.71%)
Updated
Sep 5 closing price
Capitalization
1.6B
IVVD
Price
$1.14
Change
+$0.14 (+14.00%)
Updated
Sep 5 closing price
Capitalization
238.69M
67 days until earnings call
Interact to see
Advertisement

CDTX vs IVVD

Header iconCDTX vs IVVD Comparison
Open Charts CDTX vs IVVDBanner chart's image
Cidara Therapeutics
Price$63.17
Change-$1.76 (-2.71%)
Volume$424.6K
Capitalization1.6B
Invivyd
Price$1.14
Change+$0.14 (+14.00%)
Volume$7.61M
Capitalization238.69M
CDTX vs IVVD Comparison Chart in %
Loading...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IVVD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDTX vs. IVVD commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDTX is a Hold and IVVD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CDTX: $63.17 vs. IVVD: $1.14)
Brand notoriety: CDTX and IVVD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDTX: 76% vs. IVVD: 118%
Market capitalization -- CDTX: $1.6B vs. IVVD: $238.69M
CDTX [@Biotechnology] is valued at $1.6B. IVVD’s [@Biotechnology] market capitalization is $238.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDTX’s FA Score shows that 0 FA rating(s) are green whileIVVD’s FA Score has 0 green FA rating(s).

  • CDTX’s FA Score: 0 green, 5 red.
  • IVVD’s FA Score: 0 green, 5 red.
According to our system of comparison, IVVD is a better buy in the long-term than CDTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDTX’s TA Score shows that 2 TA indicator(s) are bullish while IVVD’s TA Score has 6 bullish TA indicator(s).

  • CDTX’s TA Score: 2 bullish, 5 bearish.
  • IVVD’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, IVVD is a better buy in the short-term than CDTX.

Price Growth

CDTX (@Biotechnology) experienced а -3.40% price change this week, while IVVD (@Biotechnology) price change was +17.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

IVVD is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDTX($1.6B) has a higher market cap than IVVD($239M). IVVD YTD gains are higher at: 157.278 vs. CDTX (135.007). IVVD has higher annual earnings (EBITDA): -110.21M vs. CDTX (-208.92M). CDTX has more cash in the bank: 511M vs. IVVD (34.9M). CDTX has less debt than IVVD: CDTX (2.33M) vs IVVD (2.97M). IVVD has higher revenues than CDTX: IVVD (46.2M) vs CDTX (0).
CDTXIVVDCDTX / IVVD
Capitalization1.6B239M670%
EBITDA-208.92M-110.21M190%
Gain YTD135.007157.27886%
P/E RatioN/AN/A-
Revenue046.2M-
Total Cash511M34.9M1,464%
Total Debt2.33M2.97M79%
FUNDAMENTALS RATINGS
CDTX: Fundamental Ratings
CDTX
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CDTXIVVD
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 17 days ago
84%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IVVD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ORPB9.740.18
+1.88%
Oregon Pacific Bancorp
AIAGF87.20N/A
N/A
Aurubis Ag
NTEI0.75N/A
N/A
Nova Tech Enterprises, Inc.
ASAAF12.52N/A
N/A
AT&S Austria Technologie & SystemTechnik AG Leoben
SWSDF1087.00N/A
N/A
Swiss Life Holding

CDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDTX has been closely correlated with BPTSY. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then BPTSY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDTX
1D Price
Change %
CDTX100%
-2.71%
BPTSY - CDTX
92%
Closely correlated
N/A
UNCY - CDTX
51%
Loosely correlated
+0.93%
INDP - CDTX
39%
Loosely correlated
-28.35%
IVVD - CDTX
36%
Loosely correlated
+14.29%
CPRX - CDTX
35%
Loosely correlated
+2.47%
More

IVVD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IVVD has been loosely correlated with ENTO. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if IVVD jumps, then ENTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVVD
1D Price
Change %
IVVD100%
+14.29%
ENTO - IVVD
57%
Loosely correlated
+1.89%
GHRS - IVVD
37%
Loosely correlated
+0.28%
VIR - IVVD
37%
Loosely correlated
+2.53%
CDTX - IVVD
36%
Loosely correlated
-2.71%
AXON - IVVD
34%
Loosely correlated
-0.24%
More